New York State Common Retirement Fund Cellectis S.A. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$8.01 - $12.84 $797,796 - $1.28 Million	-99,600 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$15.7 - $20.84 $91,986 - $122,101	-5,859 Reduced 5.56%	99,600 $1.84 Million
Q2 2020 Aug 07, 2020	BUY	$8.21 - $21.02 $48,102 - $123,156	5,859 Added 5.88%	105,459 $1.88 Million
Q4 2018 Feb 08, 2019	BUY	$15.58 - $28.41 $1.55 Million - $2.83 Million	99,600 New	99,600 $1.66 Million

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $86M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.